Norman Schwartz - Aug 25, 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Chairman, President, and CEO, Director, 10%+ Owner
Signature
/s/ Norman Schwartz
Stock symbol
BIO
Transactions as of
Aug 25, 2023
Transactions value $
-$7,017,885
Form type
4
Date filed
8/28/2023, 01:29 PM
Previous filing
Dec 1, 2022
Next filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2.08K +0.49% $0.00 430K Aug 25, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$394K -1.03K -0.24% $381.78 429K Aug 25, 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +1.27K +0.3% $0.00 430K Aug 25, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$240K -628 -0.15% $381.78 430K Aug 25, 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +1.81K +0.42% $0.00 431K Aug 25, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$342K -895 -0.21% $381.78 430K Aug 25, 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2.32K +0.54% $0.00 433K Aug 25, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$439K -1.15K -0.27% $381.78 432K Aug 25, 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2.6K +0.6% $0.00 434K Aug 25, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$492K -1.29K -0.3% $381.78 433K Aug 25, 2023 Direct
transaction BIO Bio-Rad B Common Stock Options Exercise $4.58M +39K +11.76% $117.50 371K Aug 25, 2023 Direct
transaction BIO Bio-Rad B Common Stock Tax liability -$9.69M -25.4K -6.85% $381.78 345K Aug 25, 2023 Direct
holding BIO Bio-Rad B Common Stock 12.9K Aug 25, 2023 By Spouse F2
holding BIO Bio-Rad B Common Stock 4.06M Aug 25, 2023 By Blue Raven Partners, L.P. F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -2.08K -24.99% $0.00 6.25K Aug 25, 2023 Bio-Rad A Common Stock 2.08K $0.00 Direct F4, F5
transaction BIO Restricted Stock Units Options Exercise $0 -1.27K -33.33% $0.00 2.53K Aug 25, 2023 Bio-Rad A Common Stock 1.27K $0.00 Direct F4, F6
transaction BIO Restricted Stock Units Options Exercise $0 -1.81K -50% $0.00 1.81K Aug 25, 2023 Bio-Rad A Common Stock 1.81K $0.00 Direct F4, F7
transaction BIO Restricted Stock Units Options Exercise $0 -2.32K -50% $0.00 2.32K Aug 25, 2023 Bio-Rad A Common Stock 2.32K $0.00 Direct F4, F8
transaction BIO Restricted Stock Units Options Exercise $0 -2.6K -100% $0.00* 0 Aug 25, 2023 Bio-Rad A Common Stock 2.6K $0.00 Direct F4, F9
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -39K -100% $0.00* 0 Aug 25, 2023 Bio-Rad B Common Stock 39K $117.50 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 The reporting person disclaims beneficial ownership of these shares.
F3 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5 On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments, of which 2,081 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
F6 On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments, of which 1,266 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
F7 On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments, of which 1,805 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
F8 On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments, of which 2,320 vested on August 25, 2023. The remaining restricted stock units will vest on the yearly anniversary date of the grant.
F9 On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments, of which 2,600 vested on August 25, 2023.
F10 The option, representing a right to purchase a total of 39,000 shares, became exercisable in five equal annual installments beginning on September 11, 2014, which was the first anniversary of the date on which the option was granted.